Neuroendocrine dysfunction affects gonadotropin-releasing hormone production by the hypothalamic–pituitary–ovarian axis, therefore unbalancing the LH:FSH ratio in PCOS patients [1]. This evidence concerns the gene BRD2 and polycystic ovary syndrome.